Geron | GERN - Cost Of Sales


Geron reported $1.31M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Amgen USD 1.79B 128M Dec/2025
Bio Techne USD 104.6M 6.16M Dec/2025
Cassava Sciences USD 3.96M 1.16M Sep/2025
Cytokinetics USD 99.23M 13.32M Sep/2025
Esperion Therapeutics USD 51.63M 22.2M Sep/2024
Exelixis USD 26.48M 7.91M Dec/2025
Genmab DKK 57M 15M Jun/2025
Geron USD 1.31M 263K Dec/2025
Gilead Sciences USD 1.62B 50M Dec/2025
Incyte USD 121.18M 22.18M Dec/2025
MacroGenics USD 44.3M 5.4M Sep/2025
Novartis USD 3.54B 217M Sep/2025
Novavax USD 60.62M 91.77M Sep/2024